Princeton Global Asset Management LLC Alnylam Pharmaceuticals, Inc. Transaction History
Princeton Global Asset Management LLC
- $474 Million
- Q1 2025
A detailed history of Princeton Global Asset Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 25 shares of ALNY stock, worth $6,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 50
50.0%
Holding current value
$6,750
Previous $11,000
45.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
674Shares Held
108MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.48 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.44 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.58 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.88 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.18 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.2B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...